Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

SMASH

Financiado

Cerrado

The first non invasive device for continuous real time monitoring of glucose an...

The first non invasive device for continuous real time monitoring of glucose and lactate through sweat analysis Monitoring of blood glucose concentration in diabetics is mandatory for managing the pathology evolution, but it is still performed through invasive devices (mainly blood-prick tests) which cause pain and are unable to provide con... ver más

30/09/2019

Innovosens AB

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

INNOVOSENS AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-09-30

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 5 años

0% 70% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Innovosens AB

50.00K€ | Lider

TALLERES LEMAR

426.91K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 5 meses Fecha Inicio: 2019-04-26
Fecha Fin: 2019-09-30

Líder del proyecto

INNOVOSENS AB No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Monitoring of blood glucose concentration in diabetics is mandatory for managing the pathology evolution, but it is still performed through invasive devices (mainly blood-prick tests) which cause pain and are unable to provide continuous, realtime monitoring. The same shortages can be found in the monitoring of other key biomarkers, such as lactate level, which is a key factor for customizing the training of professional athletes and prevent muscle injuries, and is currently measured through prick test or ex-post through lab exams. Innovosens is a high-tech start-up company specialized in bio-chemical analysis and micro-sensing devices which developed SMASH, the first non-invasive, multiparametric wearable sensor for continuous monitoring of glucose and lactate levels. Through an innovative patented microfluidic system, the sensor is able to collect sweat from the skin, analyse both the biomarkers level, and continuously replenish the reservoir with fresh sweat for updated data. Diabetics patients will be able to measure their glucose level non-invasively, continuously and in real-time, through data wirelessly transmitted from the device to a mobile app, thus promptly reacting to acute levels with corrective dietary or drug intake. At the same time, the real-time monitoring of lactate level will provide athletes and their coaches with the unprecedented possibility to prevent lacto-acidosis, thus customising and maximising training sessions and preventing the risk of injuries. The Phase 1 project will be key for defining the final device design by interacting with end-users and key stakeholders, and for consolidating the business model by devising the most appropriate pricing and commercialization strategy, with a view to the market launch in 2021.

Conecta tu I+D

Entra hoy

Forgot your password?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores